ImmuPharma plc (IMM.L) CEO Slams Stock Plunge After Drug Trial
11/19/2009 8:18:04 AM
More...
|
ImmuPharma plc (IMM.L) Swings to H1 Profit After Cephalon, Inc. (CEPH) Deal
9/29/2009 7:13:49 AM
More...
|
ImmuPharma plc (IMM.L) Preliminary Results Announcement For The Year Ended 31 December 2008
6/24/2009 1:48:48 PM
More...
|
ImmuPharma plc (IMM.L) Lupuzor Phase IIb Study
2/2/2009 2:55:00 PM
More...
|
Cephalon, Inc. (CEPH) Exercises Option to License Worldwide Rights to ImmuPharma plc (IMM.L) Product, Lupuzor
2/2/2009 7:22:14 AM
More...
|
Cephalon, Inc. (CEPH) and ImmuPharma plc (IMM.L) Sign a $15 Million Option Agreement for Late- Stage Experimental Lupus Medication
11/25/2008 6:52:10 AM
More...
|
ImmuPharma plc (IMM.L) Positive on 2008 Progress
5/12/2008 4:34:58 PM
More...
|
ImmuPharma plc (IMM.L) Release: First Lupus Patients Dosed with IPP-201101 in Phase IIb Study
2/28/2008 4:16:31 PM
More...
|
ImmuPharma plc (IMM.L) Announces Successful Results From Its Phase I Clinical Trial With IPP-201101 For Lupus
5/10/2006 6:17:03 PM
More...
|
ImmuPharma plc (IMM.L) Commences Drawdown Of Research Grants Exceeding 1 Mln Eur
4/11/2006 2:31:52 PM
More...
|